Last reviewed · How we verify
NCT03813901
Impact of 'Samalochana' Program on Women Who Have Experienced Intimate Partner Violence (IPV)
NA trial testing Samalochana Counselling in Domestic Violence in 102 participants. Completed in 21 December 2018.
22 November 2018
Quick facts
| Lead sponsor | NMP Medical Research Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 102 |
| Start date | 21 June 2018 |
| Primary completion | 22 November 2018 |
| Estimated completion | 21 December 2018 |
| Sites | 1 location across India |
Drugs / interventions tested
- Samalochana Counselling
- Wait list control
Conditions studied
- Domestic Violence — all drugs for Domestic Violence →
- Intimate Partner Violence — all drugs for Intimate Partner Violence →
Sponsor
NMP Medical Research Institute
Who can join
Adults 18 to 50, female only, with Domestic Violence or Intimate Partner Violence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Violence has immediate effects on women's health, which in some cases, is fatal. Physical, mental and behavioural health consequences can also persist long after the violence has stopped. Violence against women and girls occurs in every country and culture and is rooted in social and cultural attitudes and norms that privilege men over women and boys over girls. Research consistently finds that the more severe the abuse, the greater its impact on women's physical and mental health. In addition, the negative health consequences can persist long after abuse has stopped.Present work shares the impact of arsha vidya counselling for women who has been victim of violence.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Psychological therapies for women who experience intimate partner violence.
Hameed M, O'Doherty L, Gilchrist G, Tirado-Muñoz J, et al · · 2020 · cited 71× · PMID 32608505 · DOI 10.1002/14651858.cd013017.pub2
Verify or expand the search:
- PubMed search for NCT03813901
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Domestic Violence
Currently open trials in the same condition.
- NCT07303608 — Improving Outcomes in Social Services Through Routine Outcome Monitoring and Systematic Client Feedback · NA · recruiting
- NCT07165860 — Clinical Trial to Reduce Perinatal Intimate Partner Violence · NA · recruiting
- NCT06979193 — Peer Counselling to Reduce Psychological Distress and Exposure to Violence Among Sexual and Gender Minorities · NA · active not recruiting
- NCT07015502 — Self-Dehumanization and Hesitation to Report Domestic Violence · recruiting
- NCT04857775 — Adaptation and Pilot Testing of Web and Mobile Interface for the ATTACH™ Intervention · NA · recruiting
Other NMP Medical Research Institute trials
Trials by the same sponsor.
- NCT04974853 — Cholesterol Lowering Effect of Cardio-Complement, an Ayurveda Formulation · NA · completed
- NCT04920773 — Community-based Post-exposure Prophylaxis for COVID-19 · NA · completed
- NCT04113512 — Yoga Nasal Irrigation in the Treatment of Chronic Tension Type Headache · NA · completed
- NCT04113460 — The Effectiveness Yoga@Work Among Office Workers With Chronic Nonspecific Neck Pain (CNNP) · NA · completed
- NCT04113473 — An Evaluation of Yoga Therapy for Cervical Spondylosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03813901 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NMP Medical Research Institute
- Last refreshed: 5 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03813901.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing